Drugs for cardiac diseases
Bansal, A.
Indian pediatrics 46(8): 737-8; author reply 738-9
2009
ISSN/ISBN: 0019-6061 PMID: 19717874 Document Number: 637896
Document emailed within 1 workday
Related Documents
Drozdowska, S. 1973: Use of cardiac drugs in diseases of the posterior segment of the eyebulb taking into account ceruloplasmin analysis and ophthalmodynamometry Klinika Oczna 43(7): 767-770Yanaginuma, T. 1987: Administration of antituberculous drugs to subjects with basic diseases. 5. Drugs for tuberculosis in the pregnant woman Kekkaku: 62(12): 680-684
Tsyplenkova, V.G. 2012: Mechanisms of cardiac hystiocyte's aging and death under noncoronary cardiac diseases Arkhiv Patologii 74(1): 22-25
Blichfeldt, P. 1975: Antiinflammatory drugs--Use of cytostatic drugs in rheumatic diseases Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(28): 1606-1608
Niimi, Y. 2004: ACC/AHA guideline for non-cardiac surgery conducted on patients with cardiac diseases Masui. Japanese Journal of Anesthesiology 53 Suppl: S122-S134
Chong, S.A.; Mythily; Mahendran, R. 2001: Cardiac effects of psychotropic drugs Annals of the Academy of Medicine Singapore 30(6): 625-631
Piuhola, J.; Tenhunen, O.; Kerkelä, R. 2015: Adverse cardiac effects associated with anticancer drugs Duodecim; Laaketieteellinen Aikakauskirja 131(5): 441-447
Lechat, P. 1997: Beta-blockers and new drugs for cardiac failure La Revue du Praticien 47(19): 2131-2134
Das, M.K.; Zipes, D.P. 2010: Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention Journal of Cardiovascular Pharmacology 55(5): 438-449
Allen, J.D.; Ekue, J.M.; Pantridge, J.F.; Shanks, R.G.; Zaidi, S.A. 1971: Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs British Journal of Anaesthesia 43(7): 720-721
Gettes, L.S. 1970: Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias Cardiovascular Clinics 2(2): 211-237
Huikuri, H. 1992: The role of drugs in the long-term management of cardiac arrhythmias Duodecim; Laaketieteellinen Aikakauskirja 108(13): 1158-1160
Yue, P.; Lü, Y.-j.; Yang, B.-f. 2006: Advances in the study of cardiac M3 receptor as a novel target of antiarrhythmic drugs Yao Xue Xue Bao 41(8): 702-705
Waschek, J.; Hinkle, G.; Basmadjian, G.; Allen, E.W.; Ice, R. 1981: Effect of cardiac drugs on imaging studies with thallous chloride Tl 201 American Journal of Hospital Pharmacy 38(11): 1726-1728
Sfrisi, C.; Cocco, G. 1984: Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests La Clinica Terapeutica 111(2): 159-167
Ikeda, H.; Sato, S.; Takahashi, K.; Kubota, I.; Yasui, S.; Miyazawa, K. 1985: Serum concentration and clinical efficacy of drugs in pulmonary and cardiac disease Rinsho Byori. Japanese Journal of Clinical Pathology 33(7): 781-787
Findlay, I. 1992: Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle Journal of Pharmacology and Experimental Therapeutics 262(1): 71-79
Martínez Martínez, J.A.; Salvati, A.; Suárez, L.D. 1986: Push of inotropic drugs in the treatment of refractory chronic cardiac insufficiency Medicina 46(3): 363-364
Zrenner, B.; Koller, B.; Rudolph, W. 1990: Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs? Herz 15(2): 90-102
Röggla, G.; Heinz, G.; Werba, E.; Hauser, I.; Röggla, M. 1998: Cardiac tamponade in a 21-year-old body builder after abuse of anabolic drugs Der Internist 39(3): 319